No Data
Stock News Premium = The Growth Market will be (Delisted) for stocks with a Market Cap of less than 10 billion yen.
＜Currently, 70% of the stocks are affected, and the impact extends to IPOs＞ The Tokyo Stock Exchange has tightened the listing maintenance standards for the Growth Market and plans to delist companies that have not reached a Market Cap of 10 billion yen after five years of listing starting in 2030. Although there is still time until the deadline, 70% of the 612 listed stocks have a Market Cap of less than 10 billion yen, and the Emerging Markets, including IPOs, will enter a period of significant transformation. It has been noted that companies showcase impressive growth rates during their IPOs but deteriorate post-listing.
Market Chatter: Medibank Acquires Medinet After AU$10 Million Investment
Although revenue decreased in the first quarter, sales of specific cell processing in the specific cell processing industry increased due to stable orders.
Medinet (2370) announced its financial results for the first quarter of the fiscal year ending September 2025 (October-December 2024) on the 13th. Revenue decreased by 17.7% year-on-year to 0.204 billion yen, with an operating loss of 0.382 billion yen (compared to a loss of 0.293 billion yen in the same period last year), an ordinary loss of 0.351 billion yen (compared to a loss of 0.291 billion yen in the same period last year), and a quarterly net loss of 0.345 billion yen (compared to a loss of 0.292 billion yen in the same period last year). Revenue from the cell processing business decreased by 17.7% year-on-year to 0.204 billion yen, and the segment loss was 0.118 billion yen (previously...
MEDINET Co., Ltd. Reports Financial Challenges in Q1 2024
Medinet: Summary of financial results for the 1st quarter of the fiscal year ending September 2025 [Japanese GAAP] (unconsolidated)
MDNT Research Memo (8): Under 'VISION2030', the second medium-term management plan is being promoted.
■ Medinet <2370> mid-term management plan 1. Overview of the second mid-term management plan Since April 2022, the management leadership has transitioned from founder Mr. Kimura to Mr. Kuhiro, and they are advancing discussions on a new mid-term management plan that incorporates new perspectives and points of discussion. The company announced "VISION2030," a corporate vision aimed at 2030 (the desired state of the company ten years later), and is utilizing a backcasting approach (a method that traces the path from the future to the present) to develop "VISION203.
